Amy L. O'Donnell MD
Amy L. O'Donnell
MD
Clinical Associate Professor
Jacobs School of Medicine & Biomedical Sciences
Specialty/Research Focus
Endocrinology, Diabetes and Metabolism
Education and Training:
- Fellowship, Internal Medicine, University of Michigan Medical Center (1991)
- Internship, Internal Medicine, University of Michigan Medical Center (1988)
- MD, Internal Medicine, University at Buffalo (1985)
- BA, Biology, Boston University (1981)
Employment:
- Clinical Associate Professor, Medicine, University at Buffalo (2006-present)
- Chief of Endocrinology Division, Medicine, VA WNY Healthcare System (1997-present)
- Attending Physician, Medicine, VA WNY Healthcare System
- Clinical Assistant Professor, Medicine, University at Buffalo (2001–2005)
- Research Assistant Professor, Medicine, University at Buffalo (1992–2001)
- Chief, Endocrine and Diabetes Clinics, Medicine, VA WNY Healthcare System (1995–1997)
- Lecturer/Research Fellow, University of Michigan Medical Center (1991–1992)
Journal Articles:
- Ali SH, O'donnell AL, Mohamed S, Mousa S, Dandona P. Overexpression of estrogen receptor-alpha in the endometrial carcinoma cell line Ishikawa: inhibition of growth and angiogenic factors. Gynecol Oncol. 2004; 95(3).
- Chang FY, Peacock JE, Musher DM, Triplett P, MacDonald BB, Mylotte JM, O'Donnell A, Wagener MM, Yu VL. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.. Medicine (Baltimore). 2003; 82(5).
- Chang FY, MacDonald BB, Peacock JE, Musher DM, Triplett P, Mylotte JM, O'Donnell A, Wagener MM, Yu VL. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance.. Medicine (Baltimore). 2003; 82(5).
- Ali SH, O'Donnell AL, Balu D, Pohl MB, Seyler MJ, Mohamed S, Mousa S, Dandona P. High levels of oestrogen receptor-alpha in tumorigenesis: inhibition of cell growth and angiogenic factors. Cell Prolif. 2001; 34(4).
- Ali SH, O'Donnell AL, Balu D, Pohl MB, Seyler MJ, Mohamed S, Mousa S, Dandona P. Estrogen receptor-alpha in the inhibition of cancer growth and angiogenesis. Cancer Res. 2000; 60(24).
- Ali SH, O'Donnell AL, Mohamed S, Mousa S, Dandona P. Stable over-expression of estrogen receptor-alpha in ECV304 cells inhibits proliferation and levels of secreted endothelin-1 and vascular endothelial growth factor. Mol Cell Endocrinol. 1999; 152(1-2).
- O'Donnell JL, O'Donnell AL, O‘Donnell AL. Prostaglandin E2 content in herniated lumbar disc disease. Spine (Phila Pa 1976). 1996; 21(14).
- O'Donnell AL, Letting DJ, DeRemer MF, Morse GD. Evidence of alkaline phosphatase interference in a zidovudine radioimmunoassay.. Antimicrob Agents Chemother. 1994; 38(12).
- Rosser LM, O‘Donnell AL, Lee KH, Morse GD. In vitro protein-binding characteristics of atevirdine and its N-dealkylated metabolite.. Antiviral Res. 1994; 25(3-4).
- O'Donnell AL, Rosen ED, Darling DS, Koenig RJ, O‘Donnell AL. Thyroid hormone receptor mutations that interfere with transcriptional activation also interfere with receptor interaction with a nuclear protein. Mol Endocrinol. 1991; 5(1).
- O'Donnell AL, Koenig RJ, O‘Donnell AL. Mutational analysis identifies a new functional domain of the thyroid hormone receptor. Mol Endocrinol. 1990; 4(5).
Professional Memberships:
- The Endocrine Society; Member
- The American Thyroid Association; Member
- American Diabetes Association; Member
- American Association of Clinical Endocrinologists; Member